LG Uplus Corp. (KRX:032640)

Regulus Therapeutics Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	409,069	374,464	622,773	663,055	712,335	466,764
Depreciation & Amortization	2,663,279	2,663,765	2,571,236	2,451,181	2,441,136	2,370,477
Loss (Gain) From Sale of Assets	22,308	17,374	24,213	40,715	25,008	-278,029
Asset Writedown & Restructuring Costs	179,485	176,134	24,946	74,222	26,952	399,346
Loss (Gain) From Sale of Investments	-	-	-	-	24	268
Loss (Gain) on Equity Investments	4,871	1,725	2,105	-3,215	807	-616
Provision & Write-off of Bad Debts	84,388	86,805	103,694	79,009	71,450	62,952
Other Operating Activities	2,396,180	2,369,746	2,330,459	2,556,319	2,140,616	2,097,284
Change in Accounts Receivable	-122,029	-66,888	-118,013	23,303	351,730	-41,464
Change in Inventory	31,389	107,040	-128,182	14,023	42,845	152,616
Change in Accounts Payable	78,885	78,938	-34,260	-173,173	259,804	-347,732
Change in Other Net Operating Assets	-2,580,148	-2,473,802	-2,423,981	-2,220,459	-2,668,204	-2,333,315
Operating Cash Flow	3,167,677	3,335,301	2,974,990	3,504,980	3,404,503	2,548,551
Operating Cash Flow Growth	4.29%	12.11%	-15.12%	2.95%	33.59%	13.14%
Capital Expenditures	-1,890,737	-1,914,986	-2,535,699	-2,288,358	-2,251,202	-2,703,443
Sale of Property, Plant & Equipment	17,133	19,218	17,401	13,534	13,368	17,325
Sale (Purchase) of Intangibles	-461,849	-485,234	-401,636	-551,793	-666,783	-244,098
Investment in Securities	-54,049	-35,616	-95,862	-54,008	-61,075	-25,064
Other Investing Activities	3,910	13,550	18,265	12,401	17,212	323,566
Investing Cash Flow	-2,376,385	-2,390,775	-2,998,197	-2,866,689	-2,944,805	-2,615,639
Short-Term Debt Issued	-	71,668	230,000	98,916	172,547	100,785
Long-Term Debt Issued	-	1,995,064	1,206,060	1,596,588	1,386,537	1,396,200
Total Debt Issued	1,926,900	2,066,732	1,436,060	1,695,504	1,559,084	1,496,985
Short-Term Debt Repaid	-	-201,668	-100,000	-98,916	-222,547	-55,785
Long-Term Debt Repaid	-	-2,220,911	-1,304,029	-1,908,861	-1,366,959	-1,112,813
Total Debt Repaid	-2,643,844	-2,422,579	-1,404,029	-2,007,777	-1,589,506	-1,168,598
Net Debt Issued (Repaid)	-716,944	-355,847	32,031	-312,273	-30,422	328,387
Repurchase of Common Stock	-	-	-	-	-100,000	-
Dividends Paid	-284,044	-284,044	-284,035	-262,157	-286,505	-177,549
Other Financing Activities	29,390	29,390	-	723	412	6,313
Financing Cash Flow	-971,598	-610,501	-252,004	-573,707	-416,515	157,151
Foreign Exchange Rate Adjustments	1,474	2,630	157	-294	956	-1,199
Net Cash Flow	-178,832	336,655	-275,054	64,290	44,139	88,864
Free Cash Flow	1,276,940	1,420,315	439,291	1,216,622	1,153,301	-154,892
Free Cash Flow Growth	90.40%	223.32%	-63.89%	5.49%	-	-
Free Cash Flow Margin	8.63%	9.71%	3.06%	8.75%	8.33%	-1.15%
Free Cash Flow Per Share	2970.83	3304.38	1022.01	2830.48	2657.86	-354.76
Cash Interest Paid	261,170	265,291	226,220	152,792	144,443	128,705
Cash Income Tax Paid	175,098	174,012	268,154	90,978	239,141	84,899
Levered Free Cash Flow	461,543	672,369	-138,419	432,342	-39,717	-692,938
Unlevered Free Cash Flow	632,547	844,572	13,201	545,202	56,003	-599,657
Change in Net Working Capital	239,162	-41,571	244,469	-258,384	79,032	576,437

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.